DexCom Long Term Debt 2010-2023 | DXCM

DexCom long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  • DexCom long term debt for the quarter ending December 31, 2023 was $2.434B, a 103.24% increase year-over-year.
  • DexCom long term debt for 2023 was $2.434B, a 103.24% increase from 2022.
  • DexCom long term debt for 2022 was $1.198B, a 39.57% decline from 2021.
  • DexCom long term debt for 2021 was $1.982B, a 18.87% increase from 2020.
DexCom Annual Long Term Debt
(Millions of US $)
2023 $2,434
2022 $1,198
2021 $1,982
2020 $1,667
2019 $1,060
2018 $1,010
2017 $328
2016 $
2015 $
2014 $2
2013 $5
2012 $7
2011 $
2010 $
2009 $46
DexCom Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $2,434
2023-09-30 $2,432
2023-06-30 $2,431
2023-03-31 $1,199
2022-12-31 $1,198
2022-09-30 $1,969
2022-06-30 $1,967
2022-03-31 $1,966
2021-12-31 $1,982
2021-09-30 $1,704
2021-06-30 $1,711
2021-03-31 $1,689
2020-12-31 $1,667
2020-09-30 $1,646
2020-06-30 $1,659
2020-03-31 $1,072
2019-12-31 $1,060
2019-09-30 $1,047
2019-06-30 $1,035
2019-03-31 $1,022
2018-12-31 $1,010
2018-09-30 $339
2018-06-30 $335
2018-03-31 $331
2017-12-31 $328
2017-09-30 $324
2017-06-30 $321
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30 $0
2015-06-30 $1
2015-03-31 $2
2014-12-31 $2
2014-09-30 $3
2014-06-30 $4
2014-03-31 $4
2013-12-31 $5
2013-09-30 $5
2013-06-30 $6
2013-03-31 $6
2012-12-31 $7
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30 $1
2010-06-30 $3
2010-03-31 $5
2009-12-31 $46
2009-09-30 $45
2009-06-30 $2
2009-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $50.661B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $217.088B 26.31
Intuitive Surgical (ISRG) United States $131.461B 79.19
Edwards Lifesciences (EW) United States $51.022B 33.20
IQVIA Holdings (IQV) United States $42.066B 24.95
IDEXX Laboratories (IDXX) United States $40.926B 48.93
Alcon (ALC) Switzerland $38.255B 28.21
STERIS (STE) Ireland $20.213B 23.92
Waters (WAT) United States $18.329B 26.30
Hologic (HOLX) United States $17.786B 19.63
SONOVA HOLDING (SONVY) Switzerland $16.523B 0.00
ShockWave Medical (SWAV) United States $12.385B 85.32
Fresenius Medical Care AG KGaA (FMS) Germany $12.347B 15.25
Sysmex ADR (SSMXY) Japan $10.045B 31.50
Teleflex (TFX) United States $9.832B 15.44
Penumbra (PEN) United States $7.615B 94.00
Masimo (MASI) United States $7.112B 39.88
Globus Medical (GMED) United States $6.740B 21.37
Glaukos (GKOS) United States $4.818B 0.00
Integer Holdings (ITGR) United States $3.740B 22.60
TransMedics (TMDX) United States $3.079B 294.16
LivaNova (LIVN) United Kingdom $3.019B 19.84
Elekta AB (EKTAY) Sweden $2.766B 18.97
PROCEPT BioRobotics (PRCT) United States $2.723B 0.00
Nihon Kohden (NHNKY) Japan $2.442B 20.65
Tandem Diabetes Care (TNDM) United States $2.369B 0.00
Integra LifeSciences Holdings (IART) United States $2.293B 9.41
Inari Medical (NARI) United States $2.164B 0.00
RxSight (RXST) United States $1.938B 0.00
Alphatec Holdings (ATEC) United States $1.764B 0.00
Veracyte (VCYT) United States $1.496B 0.00
OPKO Health (OPK) United States $0.850B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.835B 15.45
Artivion (AORT) United States $0.808B 93.43
Silk Road Medical (SILK) United States $0.767B 0.00
Paragon 28 (FNA) United States $0.764B 0.00
OrthoPediatrics (KIDS) United States $0.705B 0.00
Treace Medical Concepts (TMCI) United States $0.640B 0.00
SiBone (SIBN) United States $0.588B 0.00
Mesa Laboratories (MLAB) United States $0.572B 19.43
IRadimed (IRMD) United States $0.514B 29.86
ORTHOFIX MEDICAL INC (OFIX) United States $0.486B 0.00
Pacific Biosciences Of California (PACB) United States $0.449B 0.00
Pulse Biosciences (PLSE) United States $0.407B 0.00
Nevro (NVRO) United States $0.388B 0.00
NeuroPace (NPCE) United States $0.373B 0.00
CVRx (CVRX) United States $0.335B 0.00
Tactile Systems Technology (TCMD) United States $0.327B 11.02
AxoGen (AXGN) United States $0.280B 0.00
Sight Sciences (SGHT) United States $0.275B 0.00
EDAP TMS S.A (EDAP) France $0.261B 0.00
AngioDynamics (ANGO) United States $0.232B 0.00
Accuray (ARAY) United States $0.211B 0.00
Atossa Genetics (ATOS) United States $0.189B 0.00
908 Devices (MASS) United States $0.188B 0.00
Semler Scientific (SMLR) United States $0.180B 9.67
Alpha Tau Medical (DRTS) Israel $0.174B 0.00
Inogen (INGN) United States $0.160B 0.00
ClearPoint Neuro (CLPT) United States $0.147B 0.00
Delcath Systems (DCTH) United States $0.144B 0.00
Neuronetics (STIM) United States $0.101B 0.00
KORU Medical Systems (KRMD) United States $0.099B 0.00
Spectral Diagnostics (EDTXF) Canada $0.095B 0.00
Envoy Medical (COCH) United States $0.083B 0.00
EnVVeno Medical (NVNO) United States $0.071B 0.00
Monogram Orthopaedics (MGRM) United States $0.065B 0.00
Sensus Healthcare (SRTS) United States $0.062B 125.33
SEP Acquisition (SEPA) United States $0.061B 0.00
Autonomix Medical (AMIX) United States $0.061B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Vasomedical (VASO) United States $0.052B 9.42
Vicarious Surgical (RBOT) United States $0.049B 0.00
InspireMD (NSPR) Israel $0.045B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
DarioHealth (DRIO) United States $0.042B 0.00
Rapid Micro Biosystems (RPID) United States $0.042B 0.00
ReWalk Robotics (LFWD) Israel $0.040B 0.00
Aspira Women's Health (AWH) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.037B 0.00
LENSAR (LNSR) United States $0.036B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
PAVmed (PAVM) United States $0.019B 0.00
Biosig Technologies (BSGM) United States $0.019B 0.00
T2 Biosystems (TTOO) United States $0.018B 0.00
QT Imaging Holdings (QTI) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00